Arkolith/Insider Trading/DBTX/Form 4

Reid Laurence

See Remarks, DirectorDecibel Therapeutics, Inc. (DBTX) · full profile →Form 4 · filed Mar 17, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2023Grant(A)195K—$0221K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 16, 2023Grant(A)72K—$072K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-008873) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML